<DOC>
	<DOC>NCT02055937</DOC>
	<brief_summary>The purpose of this study is to study the impact of the immediate implant breast reconstruction for patients with mastectomy and postoperative chest wall radiotherapy</brief_summary>
	<brief_title>Immediate Implant Breast Reconstruction</brief_title>
	<detailed_description>non applicable</detailed_description>
	<criteria>Histologically confirmed breast carcinoma Patients planned for mastectomy with immediate single stage breast reconstruction using an acellular dermal matrix (Strattice™, LifeCell Corporation) Patients planned to receive postoperative chest wall irradiation Age ≥ 18 years old WHO performance status 01 Affiliation to a social security system Informed consent signed prior any study specific procedures Inflammatory breast cancer Tumors with extensive involvement of the skin Use of tissue expander Indication of postoperative chemotherapy Patients planned for bilateral mastectomy History of previously treated ipsilateral breast carcinoma Usual contraindications for ADM Medical debility precluding surgical treatment Psychological, social, geographical disorders or any other condition that would preclude study compliance (treatment modalities and study followup). Pregnancy or breast feeding Inability to attend or comply with interventions or followup scheduling, disability or difficulty preventing a proper understanding of trial instructions Legal inability or restricted legal ability</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>mastectomy, reconstruction</keyword>
</DOC>